Advertisement
Screener

INTELLIGENT BIO SOLUTIONS INC. (INBS) Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature

1.6 / 5 stars · 14/43 Roast Me

INTELLIGENT BIO SOLUTIONS INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature

INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $905.95 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2022-09-22.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2022-09-22

  • INTELLIGENT BIO SOLUTIONS INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2020-12-31 was $905.95K.
  • INTELLIGENT BIO SOLUTIONS INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2021 was $905.95K.
Period endAdjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 monthAdjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month
2021-06-30$905.95K
10-K · filed 2022-09-22
2020-12-31$905.95K
10-Q · filed 2022-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
AETHLON MEDICAL INC (AEMD)United States$0.005B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26